Evidence-Based Medicine Guidelines
Metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH)." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458355/all/Metabolic_dysfunction_associated_steatotic_liver_disease__MASLD__and_steatohepatitis__MASH_.
Metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH). Evidence-Based Medicine Guidelines. John Wiley & Sons; 2026. https://evidence.unboundmedicine.com/evidence/view/EBMG/458355/all/Metabolic_dysfunction_associated_steatotic_liver_disease__MASLD__and_steatohepatitis__MASH_. Accessed March 16, 2026.
Metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH). (2026). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/458355/all/Metabolic_dysfunction_associated_steatotic_liver_disease__MASLD__and_steatohepatitis__MASH_
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2026. [cited 2026 March 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458355/all/Metabolic_dysfunction_associated_steatotic_liver_disease__MASLD__and_steatohepatitis__MASH_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH)
ID - 458355
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458355/all/Metabolic_dysfunction_associated_steatotic_liver_disease__MASLD__and_steatohepatitis__MASH_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
